This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1967 Nov;120(5):546-50.

Agnogenic myeloid metaplasia. Natural history and treatment

M N Silverstein, M R Gomes, W H ReMine, L R Elveback

PMID: 6054588

Agnogenic myeloid metaplasia. Natural history and treatment

M N Silverstein et al. Arch Intern Med. 1967 Nov.

. 1967 Nov;120(5):546-50.

Authors

M N Silverstein, M R Gomes, W H ReMine, L R Elveback

PMID: 6054588

No abstract available

PubMed Disclaimer

Similar articles

[Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
Perugini S, Ascari E, Fontana G. Perugini S, et al. Clin Ter. 1968 Apr 15;45(1):21-60. Clin Ter. 1968. PMID: 4897957 Review. Italian. No abstract available.
Some clinical aspects of myelofibrosis: a study of 21 patients.
Corneo G, Galli C, Cortellaro M, De Pangher V, Polli E. Corneo G, et al. Haematologica. 1977 Oct;62(5):517-28. Haematologica. 1977. PMID: 412738 No abstract available.
The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
Ward HP, Block MH. Ward HP, et al. Medicine (Baltimore). 1971 Sep;50(5):357-420. doi: 10.1097/00005792-197109000-00001. Medicine (Baltimore). 1971. PMID: 4940717 Review. No abstract available.
Blood and neoplastic diseases. Myeloproliferative disorders.
Lewis SM, Szur L. Lewis SM, et al. Br Med J. 1974 Nov 16;4(5941):399-402. doi: 10.1136/bmj.4.5941.399. Br Med J. 1974. PMID: 4425895 Free PMC article. No abstract available.
Agnogenic myeloid metaplasia; its current managment.
Silverstein MN. Silverstein MN. Minn Med. 1970 Mar;53(3):257-9. Minn Med. 1970. PMID: 5415744 No abstract available.

See all similar articles

Cited by

Purification, biochemical characterization and serological analysis of cellular deoxyribonucleic acid polymerases and a reverse transcriptase from spleen of a patient with myelofibrotic syndrome.
Chandra P, Steel LK. Chandra P, et al. Biochem J. 1977 Dec 1;167(3):513-24. doi: 10.1042/bj1670513f. Biochem J. 1977. PMID: 75008 Free PMC article.
[Myelofibrosis (author's transl)].
Hunstein W, Hauswaldt C. Hunstein W, et al. Klin Wochenschr. 1974 Apr 1;52(7):305-17. doi: 10.1007/BF01468828. Klin Wochenschr. 1974. PMID: 4601278 Review. German. No abstract available.
Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in a patient with idiopathic myelofibrosis.
Takasaki M, Takahashi I, Takamatsu M, Yorimitsu S, Yorimitsu Y, Takeda I, Horimi T. Takasaki M, et al. J Gastroenterol. 1996 Apr;31(2):260-2. doi: 10.1007/BF02389527. J Gastroenterol. 1996. PMID: 8680548
Diagnostic and taxonomic challenges in chronic myelomonocytic leukemia with lymph node involvement: A case report and mini-review.
Shah B, Abdollahi-Neisani M, Taheri P, Varshavsky A, Nejati R, Mackrides N. Shah B, et al. Leuk Res Rep. 2025 Jun 14;24:100520. doi: 10.1016/j.lrr.2025.100520. eCollection 2025. Leuk Res Rep. 2025. PMID: 40612020 Free PMC article. Review.
Ruxolitinib for the treatment of myelofibrosis: its clinical potential.
Ostojic A, Vrhovac R, Verstovsek S. Ostojic A, et al. Ther Clin Risk Manag. 2012;8:95-103. doi: 10.2147/TCRM.S23277. Epub 2012 Mar 1. Ther Clin Risk Manag. 2012. PMID: 22399854 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems